Who owns Petros Pharmaceuticals, Inc.? Owners, funding and legal record

Before you sign or pay

• Court record: no federal case found under Petros Pharmaceuticals, Inc. in our court records (as of 2026-10-18).
• Bankruptcy: Petros Pharmaceuticals, Inc. reported a bankruptcy or receivership on Form 8-K, Item 1.03 (filed 2026-09-30).
• Leadership changes: the latest reported is Robert Weinstein, Chief Accounting Officer (Form 8-K filed 2026-06-18). Check you are dealing with the people now in charge.
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Iroquois Capital Management, LLC (filed 2026-02-17).

Who is behind it

Petros Pharmaceuticals, Inc.: incorporated in Delaware; business address in New York, New York; industry Pharmaceutical Preparations (Form 8-K, 2026-09-30).

Officers and directors, each with the role and the filing that names them:

• Mitchell Arnold: Executive Officer (Form D, 2023-07-21)
• Fady Boctor: Executive Officer (Form D, 2023-07-21)
• John D. Shulman: Director (Form D, 2023-07-21)
• Joshua N. Silverman: Director (Form D, 2023-07-21)
• Bruce T. Bernstein: Director (Form D, 2023-07-21)
• Gregory Bradley: Director (Form D, 2023-07-21)
• Wayne R. Walker: Director (Form D, 2023-07-21)

Money raised

Latest IPO step: Petros Pharmaceuticals, Inc. filed its final IPO prospectus, ticker PTPI (424B4, 2025-02-19).

IPO filings: 424B4, 2025-02-19, S-1/A, 2025-02-14, S-1/A, 2025-02-13, S-1/A, 2025-02-10, S-1, 2025-01-24; ticker PTPI on Nasdaq Capital Market.

Court and legal record

Bankruptcy or receivership reported on Form 8-K, Item 1.03: Form 8-K, 2026-09-30.

Red flags found

a bankruptcy or receivership report (Form 8-K, 2026-09-30).

Related pages

Bankruptcy filingsLeadership changes5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.